In conclusion, novel associations with pre-diagnostic serum levels of IL-15 and IL-16 and their modification by history of diagnosis of immune-related conditions support the importance of immune alterations in the aetiology of young- and middle-age-at-onset brain glioma years before diagnosis. This evidence concerns the gene IL16 and brain glioma.